Skip to main content

Table 3 Adjusted Change From Baseline in Hemodynamic Parameters at Week 12

From: Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension

Baseline Characteristic

Sildenafil Dose, TID

1 mg

5 mg

20 mg

Heart rate

 n

33

32

33

 LS mean (95% CI), bpm

3.4 (–1.1 to 7.9)

−0.7 (–5.2 to 3.7)

−5.0 (–9.3 to –0.8)

P value vs 20 mg TID

0.0019

0.1066

RAP

 n

33

33

34

 LS mean (95% CI), mmHg

−0.5 (–2.3 to 1.2)

−0.8 (–2.5 to 0.9)

−1.7 (–3.3 to 0)

P value vs 20 mg TID

0.2741

0.4098

mPAP

 n

33

33

34

 LS mean (95% CI), mmHg

−0.1 (–4.0 to 3.7)

−2.2 (–5.9 to 1.5)

−2.6 (–6.2 to 0.9)

P value vs 20 mg TID

0.2776

0.8458

Cardiac index

 n

32

31

30

 LS mean (95% CI), L/min/m2

0.1 (–0.2 to 0.3)

0.1 (–0.1 to 0.4)

0.1 (–0.2 to 0.3)

P value vs 20 mg TID

0.9023

0.7590

PVR

 n

32

31

30

 LS mean (95% CI), Wood units

−1.2 (–3.3 to 0.9)

−2.0 (–4.1 to 0)

−2.4 (–4.3 to –0.4)

P value vs 20 mg TID

0.3694

0.8010

PVRI

   

 n

32

31

30

 LS mean (95% CI), Wood units*m2

−1.7 (–4.9 to 1.5)

−3.1 (–6.2 to 0)

−3.5 (–6.4 to –0.5)

P value vs 20 mg TID

0.3868

0.8628

MVO2

 n

33

28

31

 LS mean (95% CI), %

1.5 (–2.2 to 5.2)

3.0 (–0.8 to 6.7)

3.0 (–0.4 to 6.4)

P value vs 20 mg TID

0.4918

0.9791

  1. bpm beats per minute, LS least squares, mPAP mean pulmonary arterial pressure, MVO 2 mixed venous oxygen saturation, PVR pulmonary vascular resistance, PVRI PVR index, RAP right atrial pressure, TID 3 times daily